Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes
about
The dopamine metabolite 3-methoxytyramine is a neuromodulatorMonoamine oxidase A and A/B knockout mice display autistic-like features.Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humansMonoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injuryBehavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient miceKey Targets for Multi-Target Ligands Designed to Combat NeurodegenerationBiochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or BBehavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.De novo microdeletion of Xp11.3 exclusively encompassing the monoamine oxidase A and B genes in a male infant with episodic hypotonia: a genomics approach to personalized medicine.Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice.Comparative gene expression profiling between human cultured myotubes and skeletal muscle tissue.Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload.Monoamine oxidase in neuropsychiatry and behavior.Forebrain-specific expression of monoamine oxidase A reduces neurotransmitter levels, restores the brain structure, and rescues aggressive behavior in monoamine oxidase A-deficient mice.Biotransformation of xenobiotics by amine oxidases.Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movementsCatecholamines 101Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humansEarly infant exposure to excess multivitamin: a risk factor for autism?Polymorphism in serotonin receptor 3B is associated with pain catastrophizing.Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A geneScreen for MAOA mutations in target human groupsEvaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred miceDopamine and renal function and blood pressure regulation.Monoamine oxidase: radiotracer chemistry and human studies.Monoamine neurotransmitter disorders--clinical advances and future perspectives.New insights into Brunner syndrome and potential for targeted therapy.Pilot study indicate role of preferentially transmitted monoamine oxidase gene variants in behavioral problems of male ADHD probands.Adaptive changes in postsynaptic dopamine receptors despite unaltered dopamine dynamics in mice lacking monoamine oxidase B.Platelet monoamine oxidase type B, MAOB intron 13 and MAOA-uVNTR polymorphism and symptoms of post-traumatic stress disorder.Pathway design using de novo steps through uncharted biochemical spaces.Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves.Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaboroles.A novel contiguous deletion involving NDP, MAOB and EFHC2 gene in a patient with familial Norrie disease: bilateral blindness and leucocoria without other deficits.
P2860
Q21091097-E319D7FD-0B5E-4353-8F32-C4788D2495C6Q24602037-0726D724-7338-46BE-AFE9-C7DDFD99C72DQ24628259-0F843B54-4804-4CC6-A20E-82A5FDBCA669Q24632770-1CC36FBD-91C6-43BA-9947-7A9EA1C6D40AQ24650165-4E180828-32E9-47BE-B52B-058DEE096B97Q28077589-5FA32B87-80E1-4F88-B5B7-468812AC7013Q28366805-EA6FB1AC-E833-4EC9-8C14-4D3FCF8865A2Q30466736-A9E395F6-F83E-4A5C-9328-C7EBDDEAE3A0Q30525587-2E615BBB-4860-4497-A957-9E48A48C9B08Q30542135-4CABEDD2-62B9-4E9A-A9BF-E03BF260DF5EQ33533459-CF1EE15B-A838-466A-89F5-B421FC6703C5Q33580858-241B48D8-E2EA-46F3-ADBA-D5F11606F29CQ33707754-558B72CE-CCA5-41B4-AE04-20E75032BA66Q33750855-74DE88BE-4C04-4D71-AE56-3A1FDC537793Q34316455-30D40DB6-98DD-4B5A-A6AC-BAFD7239ADFCQ34329643-481F5FA1-F386-4846-B4CD-E1C6681DBA30Q34611815-C69DCD68-3E07-402E-8EDF-BFCF80408F9EQ35786397-7FA80256-F2F2-49C6-85E3-F115D445F702Q36559682-9E7FC1C5-AFC0-48DA-9BAA-D9C1F0A32984Q36582359-5AA5B66D-626A-4FA2-B56A-1A4DDD9C43FFQ36702899-0E7FA16A-F4E5-43F5-BF62-7F7A3CE5FBB8Q37297649-2F1C394F-B17B-41B4-8B73-5FEA6EDA2881Q37364384-55F02EA3-DAA1-45B0-898C-FDDCB221E236Q37597815-2A4B741B-A069-435E-81A5-9C4A75627377Q37692487-C7E468AD-2190-4266-A7CA-BE06B7452CF4Q38111703-15C61FD1-A261-4FB3-9653-CFD0B0A0D651Q38354327-9A61C68A-3BDC-4A4B-9D70-E3DDE6616C15Q38590771-19EACD42-630F-48D7-968A-2A9D8433241AQ41162066-3BF0488B-199F-4914-A8BF-597889F3ACF2Q42371259-E123D8F4-3179-40E6-B852-7206B22E3081Q42475587-924C2C14-96B5-4FFB-9E48-9829481B7A77Q47437169-15C21490-5F04-4430-9EB3-1467927D24E3Q47564037-B647BDC7-C77D-4CA2-AD90-0F2E58031B74Q48300942-93933474-4F6E-4C1E-9AD5-F96C25E4A97BQ50099275-13BA6BD6-A87A-4E2B-A968-F8ACF720E9EAQ50101851-DC5185FA-E753-476A-9FD2-DB5B5CD8AD71
P2860
Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Specific genetic deficiencies ...... emical and clinical phenotypes
@ast
Specific genetic deficiencies ...... emical and clinical phenotypes
@en
Specific genetic deficiencies ...... emical and clinical phenotypes
@nl
type
label
Specific genetic deficiencies ...... emical and clinical phenotypes
@ast
Specific genetic deficiencies ...... emical and clinical phenotypes
@en
Specific genetic deficiencies ...... emical and clinical phenotypes
@nl
prefLabel
Specific genetic deficiencies ...... emical and clinical phenotypes
@ast
Specific genetic deficiencies ...... emical and clinical phenotypes
@en
Specific genetic deficiencies ...... emical and clinical phenotypes
@nl
P2093
P2860
P3181
P356
P1476
Specific genetic deficiencies ...... emical and clinical phenotypes
@en
P2093
A H van Gennip
C H Konings
D L Murphy
G Eisenhofer
H G Brunner
J W Lenders
L M Wagemakers
N G Abeling
P2860
P304
P3181
P356
10.1172/JCI118492
P407
P577
1996-02-15T00:00:00Z